These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5082597)

  • 1. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
    Alarcon RA; Meienhofer J; Atherton E
    Cancer Res; 1972 Nov; 32(11):2519-23. PubMed ID: 5082597
    [No Abstract]   [Full Text] [Related]  

  • 2. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.
    Connors TA; Cox PJ; Farmer PB; Foster AB; Jarman M
    Biochem Pharmacol; 1974 Jan; 23(1):115-29. PubMed ID: 4811053
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
    Hill DL; Laster WR; Kirk MC; el-Dareer S; Struck RF
    Cancer Res; 1973 May; 33(5):1016-22. PubMed ID: 4703116
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of the antineoplastic drug isophosphamide by rat liver microsomes.
    Allen LM; Creaven PJ
    J Pharm Pharmacol; 1972 Jul; 24(7):585-6. PubMed ID: 4403857
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
    Allen LM; Creaven PJ
    Cancer Chemother Rep; 1972 Oct; 56(5):603-10. PubMed ID: 4405717
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of isophosphamide.
    Creaven PJ; Allen LM; Alford DA; Cohen MH
    Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of ifosfamide in man and animal].
    Brock N; Hoefer-Janker H; Hohorst HJ; Scheef W; Schneider B; Wolf HC
    Arzneimittelforschung; 1973 Jan; 23(1):1-14. PubMed ID: 4353374
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.
    Alarcon RA
    Cancer Treat Rep; 1976 Apr; 60(4):327-35. PubMed ID: 1277208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.
    O'Connell TX; Berenbaum MC
    Cancer Res; 1974 Jul; 34(7):1586-91. PubMed ID: 4833912
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
    J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of isophosphamide (NSC-109724)--results and side effects.
    Bremner DN; McCormick JS; Thomson JW
    Cancer Chemother Rep; 1974; 58(6):889-93. PubMed ID: 4614898
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of mechlorethamine and isophosphamide with bovine serum albumin and rat liver microsomes.
    Allen LM; Creaven PJ
    J Pharm Sci; 1973 May; 62(5):854-6. PubMed ID: 4705708
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens.
    Pantarotto C; Bossi A; Belvedere G; Martini A; Donelli MG; Frigerio A
    J Pharm Sci; 1974 Oct; 63(10):1554-8. PubMed ID: 4436788
    [No Abstract]   [Full Text] [Related]  

  • 16. Gas chromatographic method for the determination of plasma isophosphamide (NSC-109724).
    Allen LM; Creaven PJ
    Cancer Chemother Rep; 1972 Dec; 56(6):721-3. PubMed ID: 4660630
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
    Brock N
    Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
    [No Abstract]   [Full Text] [Related]  

  • 18. Teratogenicity and neonatal toxicity of ifosfamide in mice.
    Bus JS; Gibson JE; Reinke DA
    Proc Soc Exp Biol Med; 1973 Sep; 143(4):965-70. PubMed ID: 4743716
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of the cytotoxic aldehyde acrolein during in vitro degradation of cyclophosphamide.
    Alarcon RA; Meienhofer J
    Nat New Biol; 1971 Oct; 233(42):250-2. PubMed ID: 20486278
    [No Abstract]   [Full Text] [Related]  

  • 20. The microsomal metabolism of some analogues of cyclophosphamide: 4-methylcyclophosphamide and 6-methylcyclophosphamide.
    Cox PJ; Farmer PB; Jarman M
    Biochem Pharmacol; 1975 Mar; 24(5):599-606. PubMed ID: 1125063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.